Equities research analysts expect that LHC Group, Inc. (NASDAQ:LHCG) will post earnings of $0.60 per share for the current quarter, according to Zacks. Five analysts have issued estimates for LHC Group’s earnings. The highest EPS estimate is $0.61 and the lowest is $0.60. LHC Group posted earnings of $0.48 per share during the same quarter last year, which would indicate a positive year over year growth rate of 25%. The firm is scheduled to report its next earnings results on Wednesday, May 2nd.
On average, analysts expect that LHC Group will report full-year earnings of $3.04 per share for the current fiscal year, with EPS estimates ranging from $2.65 to $3.20. For the next year, analysts expect that the company will report earnings of $3.52 per share, with EPS estimates ranging from $3.44 to $3.65. Zacks’ EPS averages are an average based on a survey of sell-side research firms that follow LHC Group.
LHC Group (NASDAQ:LHCG) last posted its quarterly earnings results on Wednesday, February 28th. The health services provider reported $0.62 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.62. The firm had revenue of $292.40 million for the quarter, compared to analyst estimates of $280.82 million. LHC Group had a net margin of 4.67% and a return on equity of 9.18%. LHC Group’s quarterly revenue was up 24.2% on a year-over-year basis. During the same period in the previous year, the business posted $0.58 earnings per share.
Several research firms have weighed in on LHCG. BidaskClub lowered shares of LHC Group from a “sell” rating to a “strong sell” rating in a report on Wednesday, March 7th. Zacks Investment Research upgraded shares of LHC Group from a “hold” rating to a “strong-buy” rating and set a $70.00 target price on the stock in a report on Tuesday, March 6th. Stephens set a $74.00 target price on shares of LHC Group and gave the company a “buy” rating in a report on Friday, March 2nd. Oppenheimer reiterated a “buy” rating and issued a $85.00 target price on shares of LHC Group in a report on Thursday, December 7th. Finally, ValuEngine lowered shares of LHC Group from a “buy” rating to a “hold” rating in a report on Friday, December 1st. One research analyst has rated the stock with a sell rating, two have issued a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the company. The company presently has a consensus rating of “Buy” and a consensus target price of $76.70.
In other LHC Group news, COO Donald Dwayne Stelly sold 14,216 shares of the business’s stock in a transaction dated Tuesday, March 13th. The shares were sold at an average price of $64.00, for a total value of $909,824.00. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 14.80% of the company’s stock.
Hedge funds have recently modified their holdings of the company. Public Employees Retirement System of Ohio lifted its holdings in shares of LHC Group by 4,288.5% in the 3rd quarter. Public Employees Retirement System of Ohio now owns 56,129 shares of the health services provider’s stock worth $3,981,000 after acquiring an additional 54,850 shares during the last quarter. BNP Paribas Arbitrage SA lifted its holdings in shares of LHC Group by 54.0% in the 3rd quarter. BNP Paribas Arbitrage SA now owns 8,662 shares of the health services provider’s stock worth $614,000 after acquiring an additional 3,037 shares during the last quarter. Vident Investment Advisory LLC acquired a new position in shares of LHC Group in the 3rd quarter worth approximately $2,448,000. Schwab Charles Investment Management Inc. lifted its holdings in shares of LHC Group by 8.7% in the 3rd quarter. Schwab Charles Investment Management Inc. now owns 113,771 shares of the health services provider’s stock worth $8,069,000 after acquiring an additional 9,078 shares during the last quarter. Finally, Bessemer Group Inc. lifted its holdings in shares of LHC Group by 17.2% in the 3rd quarter. Bessemer Group Inc. now owns 20,400 shares of the health services provider’s stock worth $1,447,000 after acquiring an additional 3,000 shares during the last quarter. Hedge funds and other institutional investors own 89.89% of the company’s stock.
LHC Group (NASDAQ:LHCG) traded up $0.27 on Wednesday, reaching $63.59. 299,373 shares of the company were exchanged, compared to its average volume of 256,806. The firm has a market capitalization of $1,157.82, a price-to-earnings ratio of 22.79, a PEG ratio of 1.49 and a beta of 0.68. LHC Group has a 52-week low of $49.06 and a 52-week high of $76.14. The company has a quick ratio of 1.97, a current ratio of 1.97 and a debt-to-equity ratio of 0.28.
WARNING: “LHC Group, Inc. (LHCG) Expected to Announce Earnings of $0.60 Per Share” was originally published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this article on another domain, it was illegally stolen and republished in violation of U.S. & international copyright and trademark law. The correct version of this article can be accessed at https://www.dispatchtribunal.com/2018/04/08/lhc-group-inc-lhcg-expected-to-announce-earnings-of-0-60-per-share.html.
LHC Group Company Profile
LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.
Get a free copy of the Zacks research report on LHC Group (LHCG)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.